We are live on ! Find out more
CO

Global Cord Blood Corporation
CO

Delisted

CO was delisted on the 23rd of September, 2022.

Back to rankings

2 hedge funds and large institutions have $67.4K invested in Global Cord Blood Corporation in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 1 → 2 (+1)

14% less capital invested

Capital invested by funds: $78.3K → $67.4K (-$10.9K)

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
1
RhumbLine Advisers
Massachusetts
$67.1K – – –
LC
2
Luminist Capital
Michigan
$248 +$248 +165 New

CO Hedge Fund Activity: Q4 2024 in Review

2 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q4 2024, worth a combined $67.4K — down 14% from $78.3K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new CO positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held Global Cord Blood Corporation (CO) as of Q4 2024, up from 1 in Q3 2024.
  • Funds reported $67.4K of Global Cord Blood Corporation stock for Q4 2024, down 14% quarter-over-quarter.
  • 1 fund opened new Global Cord Blood Corporation positions in Q4 2024 and 0 closed out, a net change of +1 holder.

Based on aggregated 13F filings for Q4 2024.